Bases and rationale of the electrochemotherapy

European Journal of Cancer, Supplement

Volumn 4, Issue 11, 2006, Pages 38-44

  Mir, L M ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Antitumour treatments; Bleomycin; Cisplatin; Electric pulses; Electrochemotherapy; Electropermeabilization; Electroporation

Indexed keywords

BLEOMYCIN; CELL DNA; CISPLATIN; FLUOROURACIL; INTERLEUKIN 2; METHOTREXATE;

ARTICLE; CELL DEATH; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; ELECTROCHEMOTHERAPY; ELECTROPORATION; HUMAN; IMMUNE SYSTEM; MELANOMA; NONHUMAN; PRIORITY JOURNAL; SAFETY; SKIN CANCER; TUMOR VASCULARIZATION;

EID: 33750500516     PISSN: 13596349     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcsup.2006.08.005     Document Type: Article

References (57)

1. Miklavcic D., Beravs K., Semrov D., Cemazar M., Demsar F., and Sersa G. The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 74 (1998) 2152-2158
2. Miklavcic D., Semrov D., Mekid H., and Mir L.M. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 1523 (2000) 73-83
3. Mir L.M., Banoun H., and Paoletti C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res 175 (1988) 15-25
4. Orlowski S., Belehradek Jr. J., Paoletti C., and Mir L.M. Transient electropermeabilization of cells in culture: increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 37 (1988) 4727-4733
5. Mir L.M., Orlowski S., Belehradek Jr. J., and Paoletti C. Electrochemotherapy: potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 27 (1991) 68-72
6. Belehradek Jr. J., Orlowski S., Poddevin B., Paoletti C., and Mir L.M. Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer 27 (1991) 73-76
7. Mir L.M., Belehradek M., Domenge C., et al. Electrochemotherapy, a new antitumor treatment: first clinical trial. C R Acad Sci III 313 (1991) 613-618
8. Belehradek M., Domenge C., Luboinski B., Orlowski S., Belehradek Jr. J., and Mir L.M. Electrochemotherapy, a new antitumor treatment: first clinical phase I-II trial. Cancer 72 (1993) 3694-3700
9. Neumann E., Schaefer-Ridder M., Wang Y., and Hofschneider P.H. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1 (1982) 841-845
10. Orlowski S., and Mir L.M. Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta 1154 (1993) 51-63
11. Pucihar G., Kotnik T., Valic B., and Miklavcic D. Numerical determination of transmembrane voltage induced on irregularly shaped cells. Ann Biomed Eng 34 (2006) 642-652
12. Gehl J., Sorensen T.H., Nielsen K., Raskmark P., Nielsen S.L., Skovsgaard T., et al. In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1428 (1999) 233-240
13. Sersa G., Cemazar M., Semrov D., and Miklavcic D. Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice. Bioelectrochem Bioenerg 35 (1996) 61-66
14. Belehradek Jr. J., Orlowski S., Ramirez L.H., Pron G., Poddevin B., and Mir L.M. Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta 1190 (1994) 155-163
15. Weaver J., and Chizmadzhev Y.A. Theory of electroporation: a review. Bioelectrochem Bioenerg 41 (1996) 135-160
16. Teissié J., Golzio M., and Rols M.P. Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge. Biochim Biophys Acta 1724 (2005) 270-280
17. Pucihar G., Mir L.M., and Miklavcic D. The effect of pulse repetition frequency on the uptake into electropermeabilized cells in vitro with possible applications in electrochemotherapy. Bioelectrochem 57 (2002) 167-172
18. Miklavcic D., Pucihar G., Pavlovec M., Ribaric S., Mali M., Macek-Lebar A., et al. The effect of high frequency electric pulses on muscle contractions and antitumor efficiency in vivo for a potential use in clinical electrochemotherapy. Bioelectrochemistry 65 (2005) 121-128
19. Poddevin B., Orlowski S., Belehradek Jr. J., and Mir L.M. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 42 S (1991) 67-75
20. Mir L.M., Tounekti O., and Orlowski S. Bleomycin: revival of an old drug. Gen Pharmacol 27 (1996) 745-748
21. Pron G., Belehradek Jr. J., and Mir L.M. Identification of a plasma membrane protein that specifically binds bleomycin. Biochem Biophys Res Commun 194 (1993) 333-337
22. Pron G., Belehradek Jr. J., Orlowski S., and Mir L.M. Involvement of the membrane bleomycin-binding sites in the bleomycin cytotoxicity. Biochem Pharmacol 48 (1994) 301-310
23. Pron G., Mahrour N., Orlowski S., Tounekti O., Poddevin B., Belehradek Jr. J., et al. Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism. Biochem Pharmacol 57 (1999) 45-56
24. Tounekti O., Pron G., Belehradek Jr. J., and Mir L.M. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 53 (1993) 5462-5469
25. Tounekti O., Belehradek Jr. J., and Mir L.M. Relationships between DNA fragmentation, chromatin condensation and changes in flow cytometry profiles detected during apoptosis. Exp Cell Res 217 (1995) 506-516
26. Tounekti O., Kenani A., Foray N., Orlowski S., and Mir L.M. The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway. Br J Cancer 84 (2001) 1272-1279
27. Heller R., Jaroszeski M.J., et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 83 (1998) 148-157
28. Panje W.R., Hier M.P., Garman G.R., Harrell E., Goldman A., and Bloch I. Electroporation therapy of head and neck cancer. Ann Otol Rhinol Laryngol 107 (1998) 779-785
29. Glass L.F., Jaroszeski M., Gilbert R., Reintgen D.S., and Heller R. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol 37 (1997) 596-599
30. Heller R., Jaroszeski M.J., Perrott R., Messina J., and Gilbert R. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res 7 (1997) 10-18
31. Hyacinthe M., Jaroszeski M.J., Dang V.V., et al. Electrically enhanced drug delivery for the treatment of soft tissue sarcoma. Cancer 85 (1999) 409-417
32. Domenge C., Orlowski S., Luboinski B., et al. Antitumor electrochemotherapy: new advances in the clinical protocols. Cancer 77 (1996) 956-963
33. Kubota Y., Mir L.M., Nakada T., Sasagawa I., Suzuki H., and Aoyama N. Successful treatment of metastatic skin lesions from bladder cancer by electrochemotherapy. J Urology 160 (1998) 1426
34. Kubota Y., Tomita Y., Tsukigi M., Kurachi H., Motoyama T., and Mir L.M. A case of perineal malignant melanoma successfully treated with electrochemotherapy. Melanoma Res 15 (2005) 133-134
35. Tada T., Matsumoto K., and Suzuki H. Electrochemotherapy significantly inhibits the growth of colon 26 tumors in mice. Surg Today 27 (1997) 506-510
36. Sersa G., Cemazar M., and Miklavcic D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res 55 (1995) 3450-3455
37. Cemazar M., Milacic R., Miklavcic D., Dolzan V., and Sersa G. Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content. Anti-Cancer Drugs 9 (1998) 525-530
38. Sersa G., Stabuc B., Cemazar M., Miklavcic D., and Rudolf Z. Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res 10 (2000) 381-385
39. Sersa G., Stabuc B., Cemazar M., Miklavcic D., and Rudolf Z. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res 6 (2000) 863-867
40. Gehl J., Skovsgaard T., and Mir L.M. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anti-Cancer Drugs 9 (1998) 319-325
41. Jaroszeski M.J., Dang V., Pottinger C., Hickey J., Gilbert R., and Heller R. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 11 (2000) 201-208
42. Mir L.M., Orlowski S., Poddevin B., and Belehradek Jr. J. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of host's defenses. Eur Cytokine Netw 3 (1992) 331-334
43. Orlowski S., An D.J., Belehradek Jr. J., and Mir L.M. Antimetastatic effects of electrochemotherapy and of histoincompatible interleukin-2 secreting cells in the murine Lewis lung tumor. Anti-Cancer Drugs 9 (1998) 551-556
44. Mir L.M., Roth C., Orlowski S., et al. Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother 17 (1995) 30-38
45. Ramirez L.H., Orlowski S., An D.J., et al. Electrochemotherapy on liver tumors in rabbits. Br J Cancer 77 (1998) 2104-2111
46. Heller L.C., Pottinger C., Jaroszeski M.J., Gilbert R., and Heller R. In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity. Melanoma Res 10 (2000) 577-583
47. Sersa G., Cemazar M., Menart V., Gaberc-Porekar V., and Miklavcic D. Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-α on SA-1 tumors in mice. Cancer Lett 116 (1997) 85-92
48. Sersa G., Cemazar M., Parkins C.S., and Chaplin D.J. Tumor blood flow changes induced by application of electric pulses. Eur J Cancer 35 (1999) 672-677
49. Gehl J., Skovsgaard T., and Mir L.M. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta 1569 (2002) 51-58
50. Cemazar M., Parkins C.S., Holder A.L., Chaplin D.J., Tozer G.M., and Sersa G. Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. Br J Cancer 84 (2001) 565-570
51. Gehl J., and Geertsen P.F. Efficient palliation of hemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 10 (2000) 585-589
52. Davalos R.V., Mir I.L., and Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 33 (2005) 223-231
53. Edd J.F., Horowitz L., Davalos R.V., Mir L.M., and Rubinsky B. In vivo results of a new focal ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 53 (2006) 1409-1415
54. Snoj M., Rudolf Z., Cemazar M., Jancar B., and Sersa G. Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. Anticancer Drugs 16 (2005) 345-348
55. Sersa G., Kranjc S., and Cemazar M. Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors. Int J Radiat Oncol Biol Phys 46 (2000) 1037-1041
56. Ceberg C.P., Brun A., Mir L.M., Persson B.R., and Salford L.G. Enhanced boron uptake in RG 2 rat gliomas by electropermeabilization in vivo - a new possibility in boron neutron capture therapy. Anticancer Drugs 5 (1994) 463-466
57. Cemazar M., Skrk J., Mitrovic B., and Sersa G. Changed delivery of boron to tumors using electroporation for boron neutron capture therapy with BSH. Br J Radiol 73 (2000) 195-200